Treatment with Rascase 1.5mg Injection

Rascase 1.5mg Injection

Description

• Category: Uricolytic agent
• Active ingredient: Rasburicase

Uses

• Treatment of acute hyperuricemia in patients receiving chemotherapy
• Prevention or treatment of hyperuricemia in patients with tumor lysis syndrome

Mechanism of action

• Converts uric acid into allantoin, a more soluble compound that can be easily excreted by the kidneys
• Reduces the levels of uric acid in the blood and prevents the development of hyperuricemia

Contraindications

• Contraindicated in patients with G6PD deficiency due to the risk of hemolysis
• Consult a doctor if you have kidney or liver disease, vision problems, lung problems, or are pregnant or planning to become pregnant

Administration

• Administered by a healthcare professional in a hospital setting
• Given as an injection into a vein (intravenous infusion) over a period of 30 minutes, once a day for up to 5 days
• Dose, route of administration, and frequency decided by the doctor based on disease condition and other factors

Safety advice

• Pregnancy: unsafe to use during pregnancy; consult a doctor if pregnant or planning for pregnancy during treatment
• Breastfeeding: it is not known if Rascase 1.5mg Injection passes into breast milk; consult a doctor before breastfeeding
• Lungs: consult a doctor if you have any lung diseases before starting treatment
• Liver: consult a doctor if you have any liver problems before starting treatment
• Alcohol: avoid consuming alcohol as it may cause dizziness
• Driving: it is unsafe to drive vehicles or operate heavy machinery after taking the injection

Side effects

• Serious: swelling of face, lips, tongue; wheezing and breathing problems
• Common: nausea, vomiting; fever; swelling; anxiety; headache; abdominal pain; constipation; diarrhea; low phosphate levels in the blood; high levels of liver enzymes in the blood; rashes

Additional information

• Store in a refrigerator (2°C to 8°C)
• Keep out of reach from children
• Avoid foods high in purines, such as red meat, organ meats, and some seafood, which can increase uric acid levels
• Avoid activities or conditions that can trigger gout attacks, such as fasting, rapid weight loss, and stress
• Drink plenty of fluids, especially water, while taking the medicine
• Avoid smoking or using tobacco products while undergoing treatment

FAQs

1. What is the purpose of Rascase 1.5mg Injection?

   • Used to prevent or treat hyperuricemia (high levels of uric acid in the blood) in patients undergoing cancer chemotherapy for leukemia, lymphoma, and solid tumor malignancies.

2. Is Rascase 1.5mg Injection supportive therapy?

   • Yes, it is an important supportive therapy for patients undergoing chemotherapy to reduce the risk of complications associated with high levels of uric acid in the blood.

3. Who should not use Rascase 1.5mg Injection?

   • Not indicated for those who have already developed acute gout or hyperuricemia due to conditions other than cancer chemotherapy.

4. What should I avoid while taking Rascase 1.5mg Injection?

   • Avoid certain medications, such as allopurinol, which is used to lower uric acid levels. Using allopurinol with Rascase 1.5mg injection together can reduce the effectiveness of rasburicase.

5. How does Rascase 1.5mg Injection work?

   • Works by converting uric acid into allantoin, a more soluble compound that can be easily excreted by the kidneys. This reduces the levels of uric acid in the blood and prevents the development of hyperuricemia.

6. Does Rascase 1.5mg Injection help to protect people who are at high risk for tumor lysis syndrome (TLS)?

   • Yes, it is often used prophylactically in individuals who are at high risk for TLS due to their cancer chemotherapy.

Tags: medical-injection, rascase-injection, medication, pharmaceutical-product, 1.5mg-dose